ADMA Biologics, Inc.

NASDAQ:ADMA

17.4 (USD) • At close December 20, 2024
Bedrijfsnaam ADMA Biologics, Inc.
Symbool ADMA
Munteenheid USD
Prijs 17.4
Beurswaarde 4,113,186,000
Dividendpercentage 0%
52-weken bereik 4.16 - 23.64
Industrie Biotechnology
Sector Healthcare
CEO Mr. Adam S. Grossman
Website https://www.admabiologics.com

An error occurred while fetching data.

Over ADMA Biologics, Inc.

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an

Vergelijkbare Aandelen

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

Akoya Biosciences, Inc. logo

Akoya Biosciences, Inc.

AKYA

2.49 USD

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

41.49 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

3.57 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.56 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

1.32 USD

Agenus Inc. logo

Agenus Inc.

AGEN

2.83 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)